OptiBiotix Health plc (LSE:OPTI) has launched its SlimBiome® ingredient within Hydroxycut, a leading weight loss supplement brand in the United States. This partnership represents a key milestone for OptiBiotix, introducing its appetite-reducing product to a large consumer base and creating potential for increased sales and shareholder value.
The product, marketed as ‘Hydroxycut Hunger Control,’ is available both online and in major retailers, including Walmart, and is supported by research demonstrating significant appetite suppression. This launch is expected to strengthen OptiBiotix’s presence in the weight management sector and enhance global brand recognition.
About OptiBiotix Health plc
Founded in March 2012, OptiBiotix Health plc operates in the life sciences industry, developing compounds that influence the human microbiome to support disease prevention, wellness, and health management. The company collaborates with international food and supplement brands to integrate its microbiome modulators into diverse products, while also producing its own consumer supplements targeting obesity, cardiovascular health, and diabetes.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply